Shoulder and Hand Syndrome after Cerebral Infarction
Conditions
Interventions
Experimental group:Acupuncture
Control group:Western medicine for external use
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Patients who meet the diagnostic criteria; 2.Patients with shoulder and hand syndrome of stage I and II after cerebral infarction with a course of 1 to 3 months; 3.Patients aged 30 to 75 years, regardless of gender; 4.Vital signs are stable and can cooperate to complete the test; 5.Voluntary participation and informed consent has been signed.
Exclusion criteria
Exclusion criteria: 1.Thalamic pain and stroke patients with limb pain caused by other diseases, such as cervical spondylosis, periarthritis of shoulder, rotator cuff injury, carpal tunnel syndrome, etc.; 2.Serious primary diseases such as cardiovascular, lung, liver, kidney and hematopoietic system complications or complications; 3.Local upper limb infection; 4.Patients who are taking or have recently taken drugs for autonomic nervous function, such as glutamine and beta-blocker; 5.Patients with cardiac pacemaker, aneurysm silver clip ligation, metal foreign body or metal prosthesis; 6.Participating in other clinical trials; 7.Pregnant or lactation patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain;edema; | — |
Secondary
| Measure | Time frame |
|---|---|
| pain;edema;Shoulder Hand Syndrome Assessment Scale;clinical effects;upper limb motor function;neuromuscular electrophysiological assessment;quality of life, mood and patient satisfaction;heart rate variability;laboratory testing;central mechanism; | — |
Countries
China
Contacts
Public ContactDu Yuanhao
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed